TrialThe Lancet. Haematology2024

Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.

Mark T Gladwin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.